Topic

Articles

The pharmaceutical industry is facing the perfect storm. Increasing healthcare costs, a changing regulatory environment and vigorous global competition coupled with the increasing complexity of small molecule and biotech drugs contributing to expensive discovery processes and clinical trials, as well as the resultant manufacturing challenges, all pose major threats to the industry.

Drinking from a fire hose

Angie Drakulich was editorial director of Pharmaceutical Technology.

The deadline for nominations for the Innovations in Pharma Science Awards is here. Check out http://pharmtech.com/Innovations to nominate your company's work in one of five areas by next week

Time is Running out for Innovation Awards

Also, Shire recalls "Daytrana" patch, Chromatide forms Scientific Advisory Board, more...

Company and People Notes: Gilead Sciences to Expand Headquarters and add 1900 Jobs, WuXi Appoints Rujian Ma as VP of Synthetic Chemistry, More

Also, Tekmira will collaborate with Bristol-Myers Squibb, Helicos Biosciences appoints Steve Lombardi CEO, more...

Company and People Notes: CSL to Acquire Talecris, Benda Appoints George Zhou COO, More...

The US Food and Drug Administration seeks contractors that will identify, describe, and evaluate potential data sources or data environments that could participate in the agency's Sentinel Initiative.

FDA Seeks Contractors for Sentinel System

Also, Ortho Biotech recalls one lot of "Procrit" due to cracked vials, more appointments at Actavis, more...

Company and People Notes: Genentech Rejects Roche's Bid, TorreyPines CEO Retires, More...

Also, Bilcare Global Clinical Supplies opens new headquarters in San Francisco, Sigurdur Oli Olafsson named CEO of Actavis Group, more...

Company and People Notes: Meda will Acquire Valeant's Western and Eastern European Businesses, Catalent Names George L. Fotiades Interim President and CEO, More...

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.

FDA and Medicare at Odds?

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA is modernizing adverse-event reporting as part of a revolution in drug-safety assessment.

Sentinel to Transform Drug Development and Oversight

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Postponement of California's deadline gives the supply chain time to refine ePedigree solutions.

Data and Artificial Intelligence